Karyopharm Therapeutics KPTI reported its Q2 earnings results on Thursday, August 4, 2022 at 07:00 AM.
Here's what investors need to know about the announcement.
Earnings
Karyopharm Therapeutics beat estimated earnings by 1.59%, reporting an EPS of $-0.62 versus an estimate of $-0.63.
Revenue was up $17.08 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.1 which was followed by a 9.79% drop in the share price the next day.
Here's a look at Karyopharm Therapeutics's past performance:
Quarter | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 |
---|---|---|---|---|
EPS Estimate | -0.63 | -0.49 | -0.67 | -0.74 |
EPS Actual | -0.53 | 0.46 | -0.69 | -0.71 |
Revenue Estimate | 34.17M | 50.49M | 25.80M | 25.64M |
Revenue Actual | 47.67M | 126.27M | 37.69M | 22.60M |
To track all earnings releases for Karyopharm Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.